Transparency Market Research in its new report titled, “Therapeutic Drug Monitoring (TDM) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” provides key insights on the therapeutic drug monitoring market. The new report anticipates that the steep rise in the demand for better healthcare for the growing urban population will drive the therapeutic drug monitoring market during the forecast period i.e, 2017 – 2025. Increased knowledge of pharmacogenetics and pharmacokinetics of drugs is inclining the clinicians towards therapeutic drug monitoring (TDM) of certain medications. Rapid increase in the prevalence of complex neurological diseases and cancer have fueled the demand for high end diagnostic methods such as genetic testing which in turn is anticipated to boost therapeutic drug monitoring (TDM) market, says the report.
The report also anticipates that the increasing investments in research and development of novel drugs and vaccines by private and government bodies will propel the demand for the therapeutic drug monitoring (TDM) market in the near future. In addition, rise in the geriatric population, especially in developing geographies and development of innovative tools in medication management are further driving this market, as per the report. “However, low research and development (R&D) returns, high infrastructure cost, stringent regulatory framework, and lack of trained resources are some of the restraints of the therapeutic drug monitoring (TDM) market,” TMR analyst mentions some of the major market restraints.
The TMR report has split the therapeutic drug monitoring (TDM) market on the basis of product type, technology, drug class, end user and region. The report has further divided the product type segment into number of equipment such as immunoassay analyzers, spectrophotometers, chromatograms, and consumables. Increasing preference for technologically advanced services, product innovation, and growing number of diseases is anticipated to fuel the therapeutic drug monitoring (TDM) market growth, TMR analyst adds. In terms of technology, the market is classified into immunoassays such as chemiluminescent assays (CLIA), enzyme-linked immunosorbent assay (ELISA), proteomics technologies, chromatography, etc. In accordance with drug class, the market is bifurcated into antiepileptics, antibiotics, psychoactive drugs, antiarrhythmic drugs, bronchodilators, immunosuppressants, and others.
On the basis of regional perspective, the therapeutic drug monitoring (TDM) market is segmented into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. Among these, North America is predicted to dominate the global therapeutic drug monitoring (TDM) market owing to the presence of superior health care base, strong regional economics, and greater emphasis on prevention and wellness by government. This trend is also reflected in other countries. The therapeutic drug monitoring (TDM) market in Europe is expected to witness rapid growth, attributed to high consciousness about wellbeing in the region coupled with increasing spending on healthcare services. Countries such as China, Japan, and India in the Asia Pacific are poised to be the most promising markets for therapeutic drug monitoring (TDM) in the near future. Major factors for the positive outlook are extensive development of health care infrastructure, and growing emphasis on research and development in the health care sector.
TMR has profiled some of the major players operating in the therapeutic drug monitoring market that include Abbott Diagnostics, Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Siemens Healthcare, Roche Diagnostics, Thermo Fisher Scientific, and Agilent Technologies.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]